Pathogenic variants (PVs) in the BRCA1 and/or BRCA2 (BRCA1/2) genes are associated with high risks of developing first and contralateral breast cancer (BC) and ovarian cancer (OC) [1]. Here, BRCA1 is linked to breast cancer.